TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 68.75
-1.15 (-1.65%)
Feb 13, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 27.89 billion as of February 13, 2026.
Market Cap
27.89B
Enterprise Value
27.19B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
68.75
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 27.89B, an increase of 199.02%. That is a compound annual growth rate of 448.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 27.43B | -39.85% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 39.10B |
| Shanghai Junshi Biosciences | 35.48B |
| Biocytogen Pharmaceuticals (Beijing) | 35.09B |
| Duality Biotherapeutics | 30.29B |
| Genscript Biotech | 27.05B |
| PegBio | 26.11B |
| InnoCare Pharma | 25.40B |
| Ascletis Pharma | 17.87B |